About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Akums Receives ANVISA GMP Certification for Sterile Manufacturing Plant, Expands Global Sterile Manufacturing Footprint

By: Newsfile

Delhi, India--(Newsfile Corp. - August 21, 2025) - Akums Drugs & Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), proudly announces that its Sterile Manufacturing Plant has been granted the prestigious Good Manufacturing Practices (GMP) certification by ANVISA, the Brazilian Health Regulatory Agency. This certification is a significant global milestone, enabling Akums to enhance its footprint in Brazil and other regulated markets across Latin America and Asia. As ANVISA is a key member of the Pharmaceutical Inspection Co-operation Scheme (PICS), the certification also opens opportunities in other PICS-recognized countries.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/9716/263057_37fe321c943879fd_001.jpg

Akums manufacturing unit at Haridwar

ANVISA's GMP certification is among the most stringent in the world and reflects adherence to globally harmonized standards of quality, safety, and compliance. The certification confirms that Akums' sterile facility in Haridwar, India, complies with Brazilian legislation and WHO-recommended Good Manufacturing Practices. The plant is now authorized to manufacture and export a broad range of sterile products to Brazil, supporting local partners with end-to-end solutions from manufacturing to commercialization.

The certified facility specializes in the production of aseptically processed powders for sterile penicillin formulations, terminally sterilized large volume parenteral (LVP) solutions, small volume parenteral (SVP) solutions, aseptically processed injectable products, ophthalmic formulations (eye drops), and nasal sprays. Built with advanced infrastructure and quality systems, the facility operates under cleanroom environments with stringent in-process controls and real-time batch monitoring, ensuring consistent delivery of safe and effective products.

This certification aligns with Akums' broader global expansion strategy to enter highly regulated markets and support pharmaceutical companies looking to scale their sterile portfolios. Brazil, being the largest pharmaceutical market in Latin America, presents significant opportunities. The sterile injectable contract manufacturing market in Brazil is projected to grow from $574 million in 2024 to $1.04 billion by 2030. Within this, sterile penicillins, LVPs, and SVPs represent a large addressable opportunity, with Brazil's estimated LVP market size expected to reach $1.2-1.5 billion by 2030, and SVPs contributing hundreds of millions in potential revenue annually.

Commenting on this achievement, Mr. Sanjeev Jain, Managing Director - Akums, said, "We are honored to receive the ANVISA GMP certification for our manufacturing Plant. Our sterile manufacturing capabilities are globally acknowledged, and we are excited to contribute further to the advancement of healthcare across borders. Importantly, this certification also enables our partners to accelerate product registrations and commercialization in Brazil and other Latin American countries, backed by our regulatory compliance and manufacturing strength."

Mr. Sandeep Jain, Joint Managing Director - Akums, added, "At Akums, we aim to empower partners with scalable, reliable, and high-quality manufacturing solutions. This certification will further strengthen our collaborations in injectables, penicillin-based products, ophthalmics, and more."

Akums Drugs & Pharmaceuticals Ltd. has long established itself as a trusted Contract Development and Manufacturing Organization (CDMO), offering more than 4100 commercialized formulations across 60+ dosage forms and therapeutic areas. The company's ability to provide end-to-end pharmaceutical solutions—from R&D and product development to large-scale manufacturing and regulatory support—makes it a preferred partner for both Indian and global clients. The ANVISA certification adds to a growing list of global regulatory approvals that Akums has received over the years. As the demand for sterile products grows globally—especially in critical care, ophthalmology, and injectable therapeutics—Akums is well-positioned to serve this market with robust infrastructure and regulatory compliance.

For any inquiries, assistance, or further information about services, please feel free to contact Akums at +91 9999012080.

Arushi Jain
Akums Drugs & Pharmaceuticals Ltd.
www.akums.in
Email - enquiry@akums.net
Phone Number - +91 9999012080
Phase -1, Ind. Area, Plot No. 131 to 133, adjoining CBSE Office, Block C, Mangolpuri, Delhi, 110083

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/263057

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.